PRESS RELEASE: Keto Software and SSH establish a two-way technology partnership
Keto Software and SSH establish a two-way technology partnership
SSH and Keto Software announce a two-way technology partnership for better defensive cybersecurity for protecting our customers’ innovation portfolio.
Keto Zero Trust Edition improves Innovation Portfolio management with defensive cybersecurity based on PrivX technologies.
“Keto Zero Trust edition is needed by our customers due to increased digitalization of product design, development, support and services of all kinds of physical and digital products.
Security has been paramount to us as ISO 27001 certification has been a compulsory requirement by most of our larger customers. Adding Zero Trust functionality we can protect our customers critical innovation, research, and development data at rest, in transit and in use.
"We are already offering the best in user-experience, and now the most cybersecure Innovation Platform available in the market”, clarifies Veijo Hytti, CEO of Keto Software, about the logic behind the new platform edition.
Innovation, research, and development are the basis for long term sustainable business success for major companies in Finance, Technology and Manufacturing. Through process and product digitalization both in internal IT solutions and digitalized products and services. Keto Software provides a platform to collect the ideas, research data, related decisions into a transparent and measurable process.
Keto Zero Trust Edition improves the defensive cybersecurity posture of the Innovation Portfolio Management with true passwordless system access, automated and optimized access control (Just-In-Time and Just-Enough-Access) and role-based access management for people operating, maintaining and developing the systems.
Keto Zero Trust Edition
- Keeps track of the events in the system, providing a full audit and access trail of your IP portfolio both in various clouds and data centers.
- Mitigates most of the cybersecurity risks caused by increased amount of remote work and 3rdparty users also across country borders.
"This two-way technology agreement with Keto Software revitalises our OEM business which offers software companies good solution for defensive cybersecurity for valuable applications and their data. This co-operation expands our market reach through embedded Zero Trust solutions and Keto Zero Trust Edition will also improve our internal processes,” says Dr. Teemu Tunkelo, CEO of SSH.
PrivX technology enables defensive cybersecurity for Keto Zero Trust Edition. For more information, please contact:
SSH Communications Security Oyj
+358 40 549 9605
Keto Software Oy
+358 50 587 1666
SSH helps organizations safeguard their mission-critical digital assets at rest, in transit and in use. We have 5,000+ customers worldwide, including 40 percent of Fortune 500 companies, and major organizations in Finance, Government, Retail, and Industrial segments. We are committed to helping our customers secure their business in the age of hybrid cloud and distributed IT and OT solutions. Our Zero Trust solutions offer safe electronic communications, secure access to servers and between servers. Our teams in North America, Europe, Asia along with a global network of certified partners ensure customer success. The company’s shares (SSH1V) are listed on Nasdaq Helsinki. www.ssh.com.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
About Keto Software
Keto Software Oy is a Finnish no-code software platform provider for innovation and development. Our customers such as Kone, OP, Metso:Outotec, Valmet, DVV, Danfoss, Fortum and Alpiq manage their idea, innovation, resource, project and risk data in one place in the Cloud. With Keto, you can digitalise and automate your development processes with an intelligent and user-friendly tool. Gain efficiency, transparency, speed up your time-to-market and increase your ROI – get Return On Innovation! ISO 27001 Certified. https://ketosoftware.com/
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
FRO – Private acquisitions of Euronav shares in exchange for Frontline shares completed28.5.2022 12:01:09 CEST | Press release
FRO – Private acquisitions of Euronav shares in exchange for Frontline shares completed Frontline Ltd. (“Frontline” or the "Company") (NYSE: FRO – OSE: FRO) announces that it has agreed to acquire a total of 5,955,705 shares in Euronav N.V. (NYSE: EURN & Euronext: EURN) (“Euronav”) representing 2.95% of the outstanding shares in privately negotiated share exchange transactions with certain shareholders of Euronav N.V. where such shareholders of Euronav N.V. receive consideration shares in Frontline. Frontline will issue a total of 8,337,986 new shares as a result of these transactions, equivalent to an exchange ratio of 1.4. Frontline will be entitled to the declared USD 0,06 dividend to be paid by Euronav on the acquired shares on 8 June 2022. Settlement is expected to take place on or about 1 June 2022 by delivery of existing shares through a share lending arrangement with Frontline's main shareholder Hemen Holding Ltd. Following completion of the issue of the new Frontline shares, F
FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma28.5.2022 00:58:29 CEST | Press release
68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1 Sustained clinical benefit from Kymriah treatment demonstrated – of patients who achieved a complete response, 85% were still in response at 12 months1 Kymriah can be administered in the outpatient setting, offering increased flexibility and potentially reducing the burden of therapy for patients and their care teams1,2 Kymriah is now FDA approved in three indications and remains the only CAR-T cell therapy approved in both adult and pediatric settings1 Basel, May 28, 2022 — Novartis today announced the US Food and Drug Administration (FDA) has granted accelerated approval for Kymriah® (tisagenlecleucel) for the treatment of adult patients with relapsed or refractory (r/r) follicular lymphoma (FL) after two or more lines of systemic therapy. In accordance with the Accelerated Approval Program, continued approval for this indicati
ObsEva Announces Corporate Updates27.5.2022 22:01:00 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland– May 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, announced today that it has entered into a waiver and amendment agreement (Amendment Agreement) with respect to its amended and restated securities purchase agreement (Securities Purchase Agreement) with certain funds and accounts managed by JGB Management, Inc. (JGB), which is structured to provide up to $135 million in borrowing capacity, available in nine tranches. The third tranche under the Securities Purchase Agreement was due to be funded on May 25, 2022. However, the tranche has not been funded as a result of ObsEva not meeting the funding condition that its volume-weighted average share price would not trade below $3.00 per share for five or more trading days during the 30 days prior to the funding date for the third tranche. Pursuant to the Am
CONDITIONS FOR PURCHASES OF CORPORATE BONDS27.5.2022 16:20:00 CEST | Press release
Bid procedure, 2022-06-01BondsBonds issued in SEK by Swedish non-financial undertakings. The following bonds are eligible for delivery: HEMSO FASTIGHETS AB: XS2173253407, 2025-05-13 HEMSO FASTIGHETS AB: XS2269194572, 2023-12-07 VASAKRONAN AB: SE0010599183, 2023-12-20 VASAKRONAN AB: XS2391917205, 2025-03-28 ESSITY AB: XS2355204608, 2025-01-17 SCANIA CV AB: XS2297918349, 2023-11-11 SCANIA CV AB: XS2382157571, 2024-09-02 ELECTROLUX AB: XS2152294679, 2023-04-06 ELECTROLUX AB: XS1969611943, 2024-03-27 Delivery of a Bond may not occur if the Counterparty has purchased the Bond from the issuer more recently than one month prior to the date of announcement of the Special terms, that is, the purchase may not have taken place after: 2022-04-27Bid date2022-06-01Bid times10.30-11.30 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)XS2173253407: 30 mln SEK +/-30 mln SEK XS2269194572: 30 mln SEK +/-30 mln SEK SE0010599183: 30 mln SEK +/-30 mln SEK XS2391917205: 30 mln SEK +/-
CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK GOVERNMENT BONDS27.5.2022 16:20:00 CEST | Press release
Bid procedure, 2022-06-03BondsSWEDEN I/L BOND: 3113. SE0009548704. 2027-12-01 SWEDEN I/L BOND: 3114, SE0013748258, 2030-06-01 Bid date2022-06-03Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)3113: 250 mln SEK +/-125 mln SEK 3114: 250 mln SEK +/-125 mln SEK Highest permitted bid volume (corresponding nominal amount)3113: 250 mln SEK per bid 3114: 250 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNot later than 10.15 (CET/CEST) on the Bid dateDelivery and payment date2022-06-08Delivery of bondsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 Stockholm, 2022-05-27 This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be